Bayer CEO Bill Anderson's plans for a radical realignment of the company to reduce bureaucracy and increase efficiency have been bolstered by union backing in Germany for major management job cuts, but any proposals to break up its three-pillar structure of pharma, consumer health and crop science will likely meet with considerable opposition.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?